ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BAFNAPH NEWS why is Bafna Pharmaceuticals Ltd price falling or rising

BAFNAPH NEWS reasons for why stock price of Bafna Pharmaceuticals Ltd is falling or rising

BAFNAPH Bafna Pharmaceuticals is falling or rising technical reasons

Technical analysis forecast of Bafna Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Bafna Pharmaceuticals BAFNAPH at this time. Stock is rising and might rise more.

It appears as if Bafna Pharmaceuticals BAFNAPH gave a large move recently.

Stock of Bafna Pharmaceuticals (BAFNAPH) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Bafna Pharmaceuticals is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Bafna Pharmaceuticals stays above 132.1, but if it comes below 132.1, then a intra day sell could be more profitable.
If you take a sell trade below 132.1, then use 132.1 as stoploss and 121.74 as target. However if you take a buy trade in Bafna Pharmaceuticals, then use 132.1 as stoploss and 144.5 as target.

BAFNAPH Bafna Pharmaceuticals is falling or rising NEWS fundamental reasons

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026. - NEWS as on 2026-04-13

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026, in which the Board of Directors has inter-alia considered and approved: (i). The appointment of M/s. K. S. Rao & Co., Chartered Accountants, - NEWS as on 2026-03-27

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-03-27

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine-Months ended December 31, 2025 as published in "Business Standard" and "Makkal Kural" on - NEWS as on 2026-02-16

Company Announcement Bafna Pharmaceuticals Limited has submitted to the Exchange, the outcome of the Board Meeting held on February 11, 2026 along with the Unaudited financial results and Limited Review Report for the Quarter and Nine Months ended December 31, 2025. - NEWS as on 2026-02-12

Company Announcement - NEWS as on 2026-02-05

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about revision in Outlook of the Credit Ratings assigned to the Bank loan facilites of the Company by ICRA Limited. - NEWS as on 2026-01-27

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2025. - NEWS as on 2026-01-09

Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of the extract of the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2025, as published in "Business Standard" and "Ma - NEWS as on 2025-11-17

Company Announcement Bafna Pharmaceuticals Limited has submitted to the Exchange, the outcome of the Board Meeting held on November 11, 2025 along with the Unaudited financial results and Limited Review Report for the Quarter and Half Year ended September 30, 2025. - NEWS as on 2025-11-12

Board Meeting to discuss Financial Results To consider and approve the Un-audited financial results for the Quarter and Half Year ended September 30, 2025 - NEWS as on 2025-11-06

More announcements and NEWS

BAFNAPH Bafna Pharmaceuticals Ltd current price & indicator signals

Moving Averages for Bafna Pharmaceuticals Ltd

  • 5Day Average: 135.46
  • 12Day Average: 122.73
  • 20Day Average: 119.92
  • 50Day Average: 111.46
  • 100Day Average: 105.85
  • 150Day Average: 114.13
  • 200Day Average: 121.17

BAFNAPH Indicators & signals

Indicator MACD (12,26,9)

126.06, 119.46, 4.76
Indicator MACD is in positive zone

Indicator ADX (14)

32.05, 35.35, 18.19
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BAFNAPH Bafna Pharmaceuticals Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Thu Apr 2026 132.81 131.00 to 137.69 0.24% 0.27 times
15 Wed Apr 2026 132.49 131.00 to 139.99 -1.82% 0.73 times
13 Mon Apr 2026 134.94 133.87 to 141.50 -4.24% 1.78 times
10 Fri Apr 2026 140.91 137.00 to 147.95 3.51% 4.18 times
09 Thu Apr 2026 136.13 127.00 to 136.13 10% 1.74 times
08 Wed Apr 2026 123.76 119.99 to 124.71 8.37% 0.23 times
07 Tue Apr 2026 114.20 113.79 to 116.25 3.12% 0.32 times
06 Mon Apr 2026 110.74 109.00 to 113.39 -0.52% 0.19 times
02 Thu Apr 2026 111.32 109.55 to 115.00 -0.57% 0.33 times
01 Wed Apr 2026 111.96 111.80 to 114.80 2.4% 0.26 times
30 Mon Mar 2026 109.34 108.42 to 118.44 -4.19% 0.24 times
27 Fri Mar 2026 114.12 111.84 to 123.60 -3.06% 3.02 times

Videos related to: BAFNAPH NEWS why is Bafna Pharmaceuticals Ltd price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

BAFNAPH NEWS why is Bafna Pharmaceuticals Ltd price falling or rising

 

Back to top